Poland· PL-100465925
Ngenla
A somatrogon product containing somatrogonum, registered in Poland by Pfizer Europe MA EEIG. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Somatrogon is registered in 14 of 19 countries.
Countries holding a registration under ATC H01AC08 (somatrogon), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Somatrogon · ATC H01AC08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of somatrogon costs, country by country.
Normalised to the WHO defined daily dose (2.4 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Somatrogon · price per daily dose (2.4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$38.71
The record
At a glance
URPL (Poland)- Active substance
- Somatrogonum
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Poland (PL)
- ATC code
- H01AC08
- ATC class
- Somatrogon
- Defined daily dose
- 2.4 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05415062388044
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Somatrogon in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNgenla 60 mgPfizer Europe MA
- CzechiaNGENLAPfizer Europe MA EEIG, Bruxelles
- SpainNGENLA 60 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAPfizer Europe Ma Eeig
- IcelandNGENLAPfizer Europe MA EEIG*
- SwedenNgenla 60 mg Injektionsvätska, lösning i förfylld injektionspennaPfizer Europe MA EEIG
- United StatesNgenlaPfizer Laboratories Div Pfizer Inc
- CanadaNGENLAPFIZER CANADA ULC
- SwitzerlandNgenla 24 mg/ 1.2 ml, Injektionslösung im FertigpenPfizer AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ngenla
- Liechtenstein · Ngenla
- Norway · Ngenla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1b3dd8f7-6bc6-4c74-ae8f-93c84ed32101 GET /v1/drugs/1b3dd8f7-6bc6-4c74-ae8f-93c84ed32101?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań we wstrzykiwaczu",
"source": "urpl",
"strength": "60 mg",
"packaging": "05415062388044 ¦ Rpz ¦ EU/1/21/1617/002 ¦ 144171\n1 wstrzykiwacz 1,2 ml",
"substance": "Somatrogonum 60 mg",
"common_name": "Somatrogonum",
"pl_product_id": "100465925",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about somatrogon.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.